Montelukast as disease modifying treatment for Parkinson’s disease: a pilot study.
Objective: To assess safety and tolerability of high dose Montelukast as a possible disease modifying treatment for Parkinson’s disease. Background: Emerging evidence suggests that the…Asymmetric synaptic density and glucose consumption in subjects with non-demented Parkinson’s Disease, as measured with [11C]UCB-J and [18F]FDG PET.
Objective: The objective of this study was to investigate asymmetric synaptic density and glucose consumption in moderate-stage non demented PD patients and the association between…Improvement of nocturia symptoms and associated quality of life in patients with Parkinson’s disease treated with foslevodopa/foscarbidopa: results from 2 phase 3 trials
Objective: To assess nocturia over time and its correlation with quality of life (QoL) in patients with Parkinson’s disease (PD) treated with foslevodopa/foscarbidopa (LDP/CDP). Background:…Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for Parkinson’s disease: Three-year data from the open-label BeyoND study
Objective: To evaluate three-year outcomes from the ND0612 BeyoND study. Background: Investigational ND0612 is in development as a 24-hour continuous, subcutaneous infusion of liquid levodopa/carbidopa…Motor evaluation of Parkinson disease and Vascular parkinsonism using the TUG encephalog application
Objective: We aimed to compare gait and parkinsonian features between PD patients, VP patients and PD patients with Vascular component (PDVC) using a smartphone-based motion…Pilot study to investigate the use of monopolar sensing to improve the efficiency of DBS programming in Parkinson’s disease
Objective: Compare the use of in-clinic monopolar sensing functionality and standard of care monopolar review for identifying optimal settings for deep brain stimulation in Parkinson’s…iCARE-PD: a multinational multicenter feasibility study of Integrated Care Networks in Parkinson disease
Objective: To evaluate the implementation of a novel pragmatic care delivery model for people living with Parkinson’s disease (PwP) Background: The intrinsic complexity of care…Pain Phenomenon in Parkinson Disease
Objective: To describe the phenomenon of pain disorder in Parkinson Disease patients. Background: Pain is one of the most common non-motor symptoms of Parkinson’s Disease…The investigation of a novel video game for identifying mild cognitive impairment in individuals with Parkinson’s disease
Objective: To develop a novel video game (VG) prototype that can effectively detect mild cognitive impairment (MCI) in Parkinson’s disease (PD) patients. Background: MCI is…Is cognitive function related to daily life gait and turning in people with Parkinson’s disease?
Objective: We investigated whether cognition and daily-life mobility are associated in people with mild-to-moderate Parkinson's disease (PD). Background: PD is responsible for more mobility disability…
- « Previous Page
- 1
- …
- 360
- 361
- 362
- 363
- 364
- …
- 553
- Next Page »